An innovative SME founded in December 2016 and committed to the discovery and development of orphan drugs for patients affected by calcium-related genetic diseases.
ChemiCare’s mission is the improvement of the quality of life of patients affected by rare diseases such as Duchenne Muscular Dystrophy and Tubular Aggregate Myopathies, and autoimmune disorders by the development of a therapy that restores the abnormal intracellular calcium level, a common feature of these diseases.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Corso Trieste, 15 A, Novara,piedmont 28100,italy
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.chemicare.it/
- HQ
- Novara, Piedmont
Chemicare | It's A Rare Thing To Care Questions
Chemicare | It'S A Rare Thing To Care's website is https://www.chemicare.it/
Chemicare | It'S A Rare Thing To Care's LinkedIn profile is https://it.linkedin.com/company/chemicare
Chemicare | It'S A Rare Thing To Care has
4 employees.
View email and phone details for 4
employees at Chemicare | It'S A Rare Thing To Care.
Chemicare | It'S A Rare Thing To Care's industry is
Biotechnology Research
Chemicare | It'S A Rare Thing To Care's top competitors are
Biovalley Investments Partner S.p.a.,
Neuro-Zone,
Chemicare,
Innovit - Italian Innovation And Culture Hub,
Bio4dreams,
Braindtech,
Prc Ticinum Lab S.r.l.,
Biomimx® Srl,
Novartis Italia,
Biorek S.r.l..
Chemicare | It'S A Rare Thing To Care's categories are Biotechnology Research
Chemicare | It'S A Rare Thing To Care's founding year is 2016
